Treatment.com AI and Rocket Doctor Celebrate Recognition from UC Berkeley, Harvard, and AARP for Leadership in Health Innovation
●These accomplishments further position Rocket Doctor as a trusted, physician-led innovator in digital health, committed to reaching underserved communities with smarter, tech-enabled care. ●At UC Berkeley's Health Engine, Rocket Doctor was selected as part of a competitive, non-dilutive accelerator focused on high-impact healthcare startups. ●At Harvard University, Dr. Cherniak was invited by Halle Tecco to speak to medical and business students about how Rocket Doctor is transforming healthcare delivery through virtual care, AI, and connected devices. ●At the AARP AgeTech Conference, Dr. Cherniak shared Rocket Doctor's approach to improving care for Medicaid and Medicare patients across the U.S., emphasizing the platform's role in addressing access, equity, and scalability for older adults.
TORONTO, ON, May 28, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and its wholly owned virtual care platform, Rocket Doctor, are proud to announce that the company has recently been recognized by three of the most prestigious organizations in healthcare innovation: UC Berkeley's Health Engine, Harvard University, and the AARP AgeTech Accelerator.
These distinctions reinforce Rocket Doctor's position as a leading voice in comprehensive virtual care and demonstrate growing recognition of its physician-led, tech-driven model for transforming access to healthcare. It also further underscores Rocket Doctor recently being awarded Clinical Innovator of the Year at the American Telemedicine Association's NEXUS 2025 Innovators Challenge.
As part of UC Berkeley's Health Engine accelerator, Rocket Doctor joined a select cohort of healthtech founders building impactful solutions to today's most pressing healthcare challenges. The non-dilutive, remote-first program provided expert mentorship, academic partnership, and strategic support to help accelerate mission and vision, gaining access to some of the world's leading faculty in health policy and digital health, and further boosting its integration into the California ecosystem.
Following the Health Engine program, Dr. Cherniak was invited to speak at Harvard University, guest lecturing in a course led by Halle Tecco, course Director at Harvard Medical School, Adjunct Professor at Columbia Business School, and founder of Rock Health. During the session, Dr. Cherniak shared the Rocket Doctor journey, detailing how the platform empowers physicians with AI-enabled tools and diagnostic devices to deliver care efficiently, virtually, and at scale, answering questions from the class and engaging in discussions around health policy and digital innovation.
Dr. Cherniak was also invited to speak at the 2025 AARP AgeTech Conference, part of the AgeTech Collaborative™ from AARP, where he shared the Rocket Doctor story with a national audience of entrepreneurs, investors, and healthcare leaders. His presentation highlighted the company's innovative approach to delivering comprehensive physician-led care, with a particular focus on supporting Medicaid and Medicare patients across the United States. As part of the conference's thought leadership programming, Dr. Cherniak outlined how Rocket Doctor is using technology to reduce barriers to care, streamline access for underserved populations, and addressing the complex needs of aging Americans through scalable, virtual-first models.
'It's an incredible privilege to engage with institutions like UC Berkeley, Harvard, and AARP - each of which plays a vital role in shaping the future of healthcare,' said Dr. William Cherniak, CEO of Rocket Doctor. 'Being selected and invited by these organizations is a strong validation of our vision to make high-quality care radically more accessible through technology, AI, and physician leadership.'
Through these platforms, Rocket Doctor continues to build meaningful relationships with innovators, researchers, and decision-makers across the health ecosystem, further accelerating its mission to transform care delivery in North America and beyond.
About Rocket Doctor Inc.
Rocket Doctor is a technology-driven digital health platform and marketplace that empowers doctors to build and manage their own virtual or hybrid practices. Its proprietary software and AI-powered tools enable providers to deliver high-quality comprehensive care remotely, with a focus on reaching underserved and remote communities across North America. By removing barriers to care and restoring physician autonomy, Rocket Doctor is redefining what modern healthcare looks like.
Visit www.rocketdoctor.io or contact media@rocketdoctor.io.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment.com AI has built a comprehensive, personalized healthcare AI engine — the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. Treatment.com AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities.
Learn more at: www.treatment.com or contact info@treatment.com.
FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO – Treatment.com AI Inc. Email: ehamza@treatment.com Media inquiries: media@rocketdoctor.io Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statement
This news release contains forward-looking statements that are based on Treatment.com AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com AI believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
8 minutes ago
- Boston Globe
Trump administration wants to end abortion coverage through Veterans Affairs
Amy Friedrich-Karnik, director of federal policy at the Guttmacher Institute, said in a statement that the change would cut off millions of veterans and their families from services. Advertisement 'Veterans have historically faced significant barriers to reproductive health care, and with the current patchwork of abortion bans and restrictions across the country, these barriers are even steeper today,' she said. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up Veterans Affairs, which provides health coverage for veterans and their dependents, did not include abortion in its coverage until 2022. President Joe Biden's administration added it months after the U.S. Supreme Court overturned Roe v. Wade and state abortion bans began kicking in. The Biden changed allowed the VA to provide abortion even in states where it was banned. The VA says in its proposal that allowing abortion is legally questionable because Congress has not specifically allowed it. The policy change would also bring the VA's coverage into line with other federal health care plans — including Medicaid and the TriCare coverage for active military members and their families — which exclude abortion in most cases. Advertisement The VA said in its filings that about 100 veterans and 40 dependents obtain abortions using the benefits each year — far below the projection the department made in 2022 of a total of 1,000 a year. The conservative law firm Alliance Defending Freedom called on the VA to drop abortion coverage in a letter last month, saying the cost or providing abortion takes other health resources away from veterans.
Yahoo
11 minutes ago
- Yahoo
Pfizer posts strong earnings despite Trump's new 'up to 250%' tariff threat
Pharmaceutical giant Pfizer reported better-than-expected quarterly results on Tuesday and improved its predictions for full-year profits, beating Wall Street expectations. The New York-based company reported second-quarter sales of $14.7 billion (€12.74bn) and earnings per share of $0.51 (€0.44). As of around 16.00 CEST, Pfizer shares were up over 4% at $24.58. "Our business is performing well and I'm pleased with the progress we achieved in the second quarter," chairman and CEO Albert Bourla said in a statement. "We continue to be actively engaged with policymakers as we navigate a complicated and rapidly evolving geopolitical environment while also remaining focused on advancing our business," Bourla continued. This despite several policies announced by the current US administration that could hurt drugmakers. Related Irish exports hit record high with pharmaceuticals showing major boost EU Commission loses on all counts in Pfizergate legal case In May, US President Donald Trump signed an executive order whereby pharmaceutical companies would be compelled to lower prices based on a "Most Favored Nation" policy. The price-slashing scheme seeks to ban drug companies from selling products in the US at prices above those in other developed countries. In Europe, the comparison becomes complex, as a significant portion pharmaceutical costs are covered by national healthcare or insurance systems, lowering prices for consumers. Experts warned at the time that this could slash their US revenues and affect availability. Even so, the president doubled down on his plans, sending letters last week to 17 drugmakers, calling for concrete steps to cut prices by 29 September. That includes agreeing to provide their full portfolio of existing medicines at no higher than European prices to every single Medicaid patient. On Tuesday, in an interview with CNBC, he announced that tariffs for pharmaceuticals and semiconductors would be coming in "next week". 'We'll be putting an initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country," he told CNBC. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
San Francisco Chronicle
38 minutes ago
- San Francisco Chronicle
Trump administration wants to end abortion coverage through Veterans Affairs
President Donald Trump's administration is calling to remove abortion coverage from the list of medical benefits for veterans and their families, saying it's not needed. The Department of Veterans Affairs posted the proposed rule change on Monday and opened a public comment period on it that runs through Sept. 3. The department said in its proposal that it wants to ensure it 'provides only needed medical services to our nation's heroes and their families.' The department says it would still provide abortion in life-threatening circumstances — something state laws allow, even in places where bans are in place. But critics of the change note that abortion would not be provided when pregnancies are the result of rape or incest. Amy Friedrich-Karnik, director of federal policy at the Guttmacher Institute, said in a statement that the change would cut off millions of veterans and their families from services. 'Veterans have historically faced significant barriers to reproductive health care, and with the current patchwork of abortion bans and restrictions across the country, these barriers are even steeper today," she said. Veterans Affairs, which provides health coverage for veterans and their dependents, did not include abortion in its coverage until 2022. President Joe Biden's administration added it months after the U.S. Supreme Court overturned Roe v. Wade and state abortion bans began kicking in. The Biden changed allowed the VA to provide abortion even in states where it was banned. The VA says in its proposal that allowing abortion is legally questionable because Congress has not specifically allowed it. The policy change would also bring the VA's coverage into line with other federal health care plans — including Medicaid and the TriCare coverage for active military members and their families — which exclude abortion in most cases. The VA said in its filings that about 100 veterans and 40 dependents obtain abortions using the benefits each year — far below the projection the department made in 2022 of a total of 1,000 a year. The conservative law firm Alliance Defending Freedom called on the VA to drop abortion coverage in a letter last month, saying the cost or providing abortion takes other health resources away from veterans.
